The reported results obtained by Zubel et al. (2009), according to which the ADAM9 protein was found to be expressed in 93% of cervical cancer cases, generally correspond to the data of Isa et al. (2019), who identified ADAM9 in a slightly smaller number of carcinomas—75.8%—which may be due to methodological differences [52]. This evidence concerns the gene ADAM9 and cervical carcinoma.